3 most recent filings and news items mentioning Q32. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/Q32/news?limit=20"
Pull Q32 filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayQ32 Bio Inc. agreed to sell shares and pre-funded warrants to underwriters including Morgan Stanley. The proposed transaction aims to raise capital under an existing S-3 registration statement.
View filing at SEC.gov →Q32 Bio Inc. released 36-week topline results for the Part B of its Phase 2a SIGNAL-AA clinical trial. These data are critical for assessing the efficacy and safety profile of bempikibart in treating alopecia areata.
View filing at SEC.gov →Q32 Bio Inc. filed an 8-K exhibiting pre-funded warrant terms dated May 26, 2026, allowing holders to purchase common shares at specified exercise prices. The offering expands the company's capital raising toolkit through derivative securities.
View filing at SEC.gov →